ClinicalTrials.govcontrolled
Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Chinese Patients With Neovascular Age-Related Macular Degeneration
ClinicalTrials.gov study NCT04047472. IPD Sharing: YES. Countries: 1. Publications: 0.
ShareScore
32/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 16
- Harmonization
- 8
- Access
- 4
- Reuse readiness
- 0
- Engagement
- 4